As shown in Figure 5A, because of the EPR effect, these nanoparticles collect within tumors, Targeted delivery of PS and checkpoint inhibitor slowed tumor regrowth, prevented lung metastasis, and increased CD8+ T cells systemically (75). The gene discussed is CD8A; the disease is neoplasm.